Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551.

Article  PubMed  Google Scholar 

Howell J, Pedrana A, Schroeder SE, et al. A global investment framework for the elimination of hepatitis b. J Hepatol. 2021;74(3):535–49. https://doi.org/10.1016/j.jhep.2020.09.013.

Article  PubMed  Google Scholar 

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55. https://doi.org/10.1016/S0140-6736(15)61412-X.

Article  PubMed  Google Scholar 

Wild CP, Miller JD, Groopman JD, editors. Mycotoxin control in low- and middle-income countries. International Agency for Research on Cancer: Lyon; 2015. PMID: 27030861.

Cheng P, Cheng Y, Su MX, et al. Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma. Asian Pac J Cancer Prev. 2012;13(8):3741–5. https://doi.org/10.7314/apjcp.2012.13.8.3741.

Article  PubMed  Google Scholar 

Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577–86. https://doi.org/10.1002/hep.28785.

Article  PubMed  Google Scholar 

Lu W, Jin XL, Yang C, et al. Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: a single-center randomized controlled trial. Cancer Biol Ther. 2017;18(6):433–8. https://doi.org/10.1080/15384047.2017.1323589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19(1):26–44. https://doi.org/10.1038/s41575-021-00508-3.

Article  PubMed  Google Scholar 

Huang A, Yang XR, Chung WY, Dennison AR, Zhou J. Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5(1):146. https://doi.org/10.1038/s41392-020-00264-x.

Article  PubMed  PubMed Central  Google Scholar 

Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188314. https://doi.org/10.1016/j.bbcan.2019.188314.

Article  CAS  PubMed  Google Scholar 

Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036. PMID: 33042631.

CAS  PubMed  PubMed Central  Google Scholar 

Jadlowiec CC, Taner T. Liver transplantation: current status and challenges. World J Gastroenterol. 2016;22:4438–45. https://doi.org/10.3748/wjg.v22.i18.4438.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68. https://doi.org/10.1186/s13287-019-1165-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sobhani A, Khanlarkhani N, Baazm M, et al. Multipotent stem cell and current application. Acta Med Iran. 2017;55(1):6–23. PMID: 28188938.

PubMed  Google Scholar 

Gargett CE. Adult stem cells in the human endometrium. In: Simon C, Pellicer A, editors. Stem Cells in Human Reproduction: Basic Science and Therapeutic Potential. 2nd ed. London: Informa Healthcare; 2009. p. 160–76.

Google Scholar 

Larijani B, Esfahani EN, Amini P, et al. Stem cell therapy in treatment of different diseases. Acta Med Iran. 2012;50(2):79–96. PMID: 22359076.

PubMed  Google Scholar 

Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008;132:567–82. https://doi.org/10.1016/j.cell.2008.01.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Xie T. Stem cell niche: structure and function. Ann Rev Cell Dev Biol. 2005;21:605–31. https://doi.org/10.1146/annurev.cellbio.21.012704.131525.

Article  CAS  Google Scholar 

Fu RH, Wang YC, Liu SP, Huang CM, Kang YH, Tsai CH, et al. Differentiation of stem cells: strategies for modifying surface biomaterials. Cell Transplant. 2010;20:37–47. https://doi.org/10.3727/096368910X532756.

Article  PubMed  Google Scholar 

Bibber B, Sinha G, Lobba AR, Greco SJ, Rameshwar P. A review of stem cell translation and potential confounds by cancer stem cells. Stem Cells Int. 2013;2013:241048. https://doi.org/10.1155/2013/241048.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76. https://doi.org/10.1016/j.cell.2006.07.024.

Article  CAS  PubMed  Google Scholar 

Niibe K, Kawamura Y, Araki D, et al. Purified mesenchymal stem cells are an efficient source for iPS cell induction. PLoS One. 2011;6:e17610. https://doi.org/10.1371/journal.pone.0017610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J. Induced pluripotent stem cell-derived neural stem cells: new hope for stroke? Stem Cell Res Ther. 2013;4:115. https://doi.org/10.1186/scrt326.

Article  PubMed  PubMed Central  Google Scholar 

Sun S, Li Z, Glencer P, et al. Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology. Stem Cell Res Ther. 2017;8(1):135. https://doi.org/10.1186/s13287-017-0584-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao D, Cui D, Wang B, et al. Treatment of early-stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325–30. https://doi.org/10.1016/j.bone.2011.11.002.

Article  PubMed  Google Scholar 

Shahjalal HM, Dayem AA, Lim KM, Jeon TI, Cho SG. Generation of pancreatic β cells for treatment of diabetes: advances and challenges. Stem Cell ResTher. 2018;9:355. https://doi.org/10.1186/s13287-018-1099-3.

Article  CAS  Google Scholar 

Smith CL, Chaichana KL, Lee YM, et al. Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer. Stem Cells Transl Med. 2015;4(3):239–51. https://doi.org/10.5966/sctm.2014-0149.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma F, Chen D, Chen F, et al. Human umbilical cord mesenchymal stem cells promote breast cancer metastasis by interleukin-8- and interleukin-6-dependent induction of CD44(+)/CD24(-) cells. Cell Transplant. 2015;24(12):2585–99. https://doi.org/10.3727/096368915X687462.

Article  PubMed  Google Scholar 

Xie C, Yang Z, Suo Y. Systemically infused mesenchymal stem cells show different homing profiles in healthy and tumor mouse models. Stem Cells Transl Med. 2017;6(4):1120–31. https://doi.org/10.1002/sctm.16-0204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest. 2013;123(5):1911–8. https://doi.org/10.1172/JCI66024.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ye J, Sun D, Yu Y, Yu J. Osthole resensitizes CD133+ hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway. Aging (Albany NY). 2020;12(14):14406–17. https://doi.org/10.18632/aging.103484.

Article  CAS  PubMed  Google Scholar 

Wang X, Wang R, Bai S, et al. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):505. https://doi.org/10.1186/s13046-019-1508-1. Published 2019 Dec 30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng H, Pomyen Y, Hernandez MO, et al. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology. 2018;68(1):127–40. https://doi.org/10.1002/hep.29778.

Article  PubMed  Google Scholar 

Chen L, Wu M, Ji C, et al. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2. IUBMB Life. 2020;72(2):285–95. https://doi.org/10.1002/iub.2166.

Article  CAS  PubMed  Google Scholar 

Liu L, Borlak J. Advances in liver cancer stem cell isolation and their characterization. Stem Cell Rev Rep. 2021;17(4):1215–38. https://doi.org/10.1007/s12015-020-10114-6.

Article  CAS  PubMed